SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen
DNDN
|
|
|
+0.39%
in
2 days
On 11/2/09, Dendreon (NASDAQ: DNDN) announced that it has completed the submission of its amended Biologics License Application (BLA) for PROVENGE (sipuleucel-T), seeking approval for men with metastatic castrate-resistant prostate cancer (CRPC). The amended BLA includes data from the IMPACT trial, which was conducted under a Special Protocol Assessment agreement with the FDA. The IMPACT study met its pre-specified primary endpoint demonstrating a statistically significant improvement in overall survival in men with metastatic CRPC. <> PROVENGE is currently available through several ong...
|
New Global Equity Index to Track Immunotherapy, Vaccine Stocks
DNDN
|
|
|
+5.55%
in
16 days
(closed on 11/20/09)
Earlier this week, Dendreon (NASDAQ: DNDN ) announced that it has completed the submission of its amended Biologics License Application ( BLA ) for PROVENGE (sipuleucel-T), seeking approval for men with metastatic castrate-resistant prostate cancer ( CRPC ). The amended BLA includes data from the IMPACT trial, which was conducted under a Special Protocol Assessment agreement with the FDA. The IMPACT study met its pre-specified primary endpoint demonstrating a statistically significant improvement in overall survival in men with metastatic CRPC. <> PROVENGE is currently ava...
|
New Stock Indexes to Track Trends in Healthcare Sector
DNDN
|
|
|
-0.86%
in
7 days
(closed on 11/04/09)
Coming Soon. . . a premium service offered in collaboration with Investars YOU for full access to a global database of over 1,000 stocks which are organized and managed within my 20 ProActive HavRx stock indexes . The expected pricing for premium access is $60 per year and will include full access to all of the component stocks in the indexes and tracking data for the indexes. <> Emerging Cancer Diagnostic / Therapeutic (Dx / Tx) Index
The actively managed HavRx Emerging Cancer Dx / Tx Index constituents reflect a cross-section of emerging cancer companies with <><><><><><><><><><><><><><><><><><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< /><><><><><><><><><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< /><><><><><><><><><>...
|
Quantum Immunologics: Developing Universal Therapeutic Cancer Vaccine
DNDN
|
|
|
-3.58%
in
3 days
(closed on 10/28/09)
<> <> Quantum Immunologics (QI) (privately held) is dedicated to improving the treatment outcome and quality of life for cancer patients through the research, development, and production of innovative therapeutic and diagnostic products that are based on the universal cancer antigen (oncofetal antigen or OFA). Quantum’s integrated approach to the treatment, diagnosis, and monitoring of cancer is being developed to create novel, individualized products and services that offer a greatly reduced cost, a high rate of efficacy, and minimal side effects compared to conventional treatments such as ra<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>...
|
ImmunoCellular (OTC: IMUC.OB): Top Gainer in Cancer Immunotherapy Index
DNDN
|
|
|
+4.25%
in
39 days
(closed on 10/25/09)
<> The Mentor Capital Cancer Immunotherapy (CI) Index of 10 leading cancer immunotherapy stocks has increased 58% in its first two months of reporting. The CI Index gain was paced by the 233% share price improvement of ImmunoCellular Theraputics, Inc. (OTC: IMUC.OB) under the leadership of CEO Manish Singh, PhD. The increased interest in the immunotherapy companies and growth of the sector followed the positive Phase 3 results of Dendreon (NASDAQ: DNDN), a CI Index component company, for its prostate cancer product Provenge and resulting 1,000% share price improvement during the Spring of 200...
|
From the Blogosphere
Still a Lot of Potential in Dendreon and the Cancer Immunotherapy Market
<>Dendreon (DNDN) released an update on Thursday that outlined the path that the company is taking to advance its prostate cancer treatment Provenge to market.
In a mid-day PR, the company announced that they will file an NDA with the FDA in November and that the FDA would then be expected to act on the application by mid 2010. It is expected that the FDA will rule to approve Provenge, based on previous comments by the regulatory agency after mid term results were released last year. Keep in mind, however, that nothing is a sure thing both with regard to the stock market or the FDA. While indi...
|
Antigenics' Current Price is Irresistible
I've spent plenty of time discussing the potential of Antigenics (AGEN) as one of a few candidates to become the next Dendreon (DNDN) and I once again could not refuse adding to my position for just under $2.
As I've also mentioned before, AGEN is one of only a few stocks in which I'm willing to 'average up' in my position and this latest buy brings my average to just around the $1 level.
|
Trading Radar for 8/11: Cree (CREE), tw telecom (TWTC), Dendreon (DNDN), 3SBio (SSRX), Farmer Mac (AGM), Fossil (FOSL), Bob Evans Farms (BOBE) Report; Preliminary Productivity, Wholesale Inventories D
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Economics:8:30am ET - Preliminary Productivity for Q2
Earnings:Fossil (Nasdaq: FOSL) - consensus EPS $0.20Fuel Tech (Nasdaq: FTEK) - consensus loss $0.03 KongZhong (Nasdaq: KONG) - consensus EPS $0.06<u>Intraday or Not Specified:</u>Economics:10am ET - Wholesale Inventories for June
Earnings:Cree (Nasdaq: CREE) - consensus EPS $0.17Federal Agricultural Mortgage (Farmer Mac) (NYSE: AGM)Green Plains Renewable Energy (Nasdaq: GPRE)HearUSA (NYSE: EAR) - consensus loss $0.01...
|
Trading Radar for 8/11: Cree (CREE), tw telecom (TWTC), Dendreon (DNDN), 3SBio (SSRX), Farmer Mac (AGM), Fossil (FOSL), Bob Evans Farms (BOBE) Report; Preliminary Productivity, Wholesale Inventories D
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Economics:8:30am ET - Preliminary Productivity for Q2
Earnings:Fossil (Nasdaq: FOSL) - consensus EPS $0.20Fuel Tech (Nasdaq: FTEK) - consensus loss $0.03 KongZhong (Nasdaq: KONG) - consensus EPS $0.06<u>Intraday or Not Specified:</u>Economics:10am ET - Wholesale Inventories for June
Earnings:Cree (Nasdaq: CREE) - consensus EPS $0.17Federal Agricultural Mortgage (Farmer Mac) (NYSE: AGM)Green Plains Renewable Energy (Nasdaq: GPRE)HearUSA (NYSE: EAR) - consensus loss $0.01...
|
Trading Radar for 8/11: Cree (CREE), tw telecom (TWTC), Dendreon (DNDN), 3SBio (SSRX), Farmer Mac (AGM), Fossil (FOSL), Bob Evans Farms (BOBE) Report; Preliminary Productivity, Wholesale Inventories D
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Economics:8:30am ET - Preliminary Productivity for Q2
Earnings:Fossil (Nasdaq: FOSL) - consensus EPS $0.20Fuel Tech (Nasdaq: FTEK) - consensus loss $0.03 KongZhong (Nasdaq: KONG) - consensus EPS $0.06<u>Intraday or Not Specified:</u>Economics:10am ET - Wholesale Inventories for June
Earnings:Cree (Nasdaq: CREE) - consensus EPS $0.17Federal Agricultural Mortgage (Farmer Mac) (NYSE: AGM)Green Plains Renewable Energy (Nasdaq: GPRE)HearUSA (NYSE: EAR) - consensus loss $0.01...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on DNDN |
Visit streetinsider.com
|
|
|
|
tanumoy
(+107.70% risk: conservative)
|
|
|
More Resources
|
About Dendreon Corp
- Answers.com
